ABT
NYSE
$101.70
Abbott Laboratories (ABT)
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $118.33 (+16.36%)
Market Cap
$156B
Forward P/E
18.38
P/E Ratio
26.70
Free Cash Flow Yield
4.74%
Price Chart
Valuation
Market Cap$156B
P/E26.70
Forward P/E18.38
PEG7.12
P/S3.43
P/B3.08
Profitability
Total Revenue (TTM)$45B
Gross Profit (TTM)$26B
EBITDA$9.18B
Profit Margin9.7%
Operating Margin12.1%
EPS$3.34
Financial Health
Debt-to-Equity65.4%
Free Cash Flow Yield4.74%
Dividend Yield2.51%
Growth & Risk
EPS 5Y CAGR+14.67%
Revenue 5Y CAGR+3.87%
FCF 5Y CAGR-0.61%
Dividends 5Y CAGR+12.42%
Beta (5Y)0.18
Sharpe Ratio-0.57